logo

For the Inventor, By the Inventor

Letchworth, United Kingdom

Colin Houston MacPhee

USPTO Granted Patents = 13 

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 41(Granted Patents)


Company Filing History:

goldMedal12 out of 2,198 
 
Smithkline Beecham Corporation
 patents
silverMedal1 out of 7 
 
Smithkline Beechman Corporation
 patents

Years Active: 1999-2012

Loading Chart...
13 patents (USPTO):Explore Patents
1. 8088886 - [object Object] (2012-01-03),
2. 7314742 - Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy (2008-01-01),
3. 7045329 - Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy (2006-05-16),
4. 6369045 - Phospholipase A2 inhibitors thereof and use of same in diagnosis and therapy (2002-04-09),
5. 6348341 - Human p101 regulatory polypeptide (2002-02-19),
6. 6261819 - Compounds (2001-07-17),
7. 6258580 - P101 Polypeptides (2001-07-10),
8. 6238886 - Compounds (2001-05-29),
9. 6232084 - Platelet factor-4 receptor assay (2001-05-15),
10. 6200777 - Human p101 polynucleotides (2001-03-13),
11. 6177257 - Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy (2001-01-23),
12. 6174716 - Compounds (2001-01-16),
13. 5981252 - Lipoprotein associated phospholipase A.sub.2, inhibitors thereof and use (1999-11-09),

Title: The Innovative Contributions of Colin Houston MacPhee

Introduction: Colin Houston MacPhee, an esteemed inventor based in Letchworth, GB, has made significant contributions to the field of biotechnology. With a remarkable portfolio of 13 patents, his innovations are noted for their potential applications in health and therapeutic treatments.

Latest Patents: Among his latest patents, MacPhee has developed groundbreaking work on the enzyme Lipoprotein associated phospholipase A2 (Lp-PLA2). His patents include a purified form of Lp-PLA2, an isolated nucleic acid molecule encoding Lp-PLA, the utilization of an Lp-PLA2 inhibitor for therapy, and a method for screening compounds that effectively inhibit the enzyme. These innovations highlight his dedication to advancing medical research and therapeutic solutions.

Career Highlights: Throughout his career, Colin has worked for notable companies, including SmithKline Beecham Corporation. His expertise has allowed him to contribute prominently to research and development teams focused on enzyme-related therapies. The number of patents he holds reflects his commitment to pushing the boundaries of science and technology.

Collaborations: In his journey as an inventor, Colin has collaborated with skilled professionals such as David Graham Tew and Lisa Patel. These collaborations have undoubtedly enriched his projects and fostered knowledge sharing in the field.

Conclusion: Colin Houston MacPhee stands as a testament to the potential innovations that can arise from dedication and collaboration in the field of biotechnology. His patents not only showcase his ingenuity as an inventor but also pave the way for future advancements in medical therapies targeting critical enzymes. His work will continue to inspire and influence new generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…